CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2022	$ 187,375	$ 666,277	$ (225)	$ (478,677)
Balance, Shares at Dec. 31, 2022		32,141,368
Issuance of common stock upon the exercise of common stock options	3,574	$ 3,574
Issuance of common stock upon the exercise of common stock options, Shares		378,500
Issuance of common stock in connection with employee stock purchase plan	384	$ 384
Issuance of common stock in connection with employee stock purchase plan, Shares		14,135
Stock-based compensation expense	3,921	$ 3,921
Foreign currency translation adjustment	7		7
Net income (loss)	(2,636)			(2,636)
Balance at Mar. 31, 2023	192,625	$ 674,156	(218)	(481,313)
Balance, Shares at Mar. 31, 2023		32,534,003
Balance at Dec. 31, 2022	187,375	$ 666,277	(225)	(478,677)
Balance, Shares at Dec. 31, 2022		32,141,368
Foreign currency translation adjustment	5
Net income (loss)	(3,637)
Balance at Jun. 30, 2023	145,213	$ 627,747	(220)	(482,314)
Balance, Shares at Jun. 30, 2023		32,582,933
Balance at Mar. 31, 2023	192,625	$ 674,156	(218)	(481,313)
Balance, Shares at Mar. 31, 2023		32,534,003
Issuance of common stock upon the exercise of common stock options	705	$ 705
Issuance of common stock upon the exercise of common stock options, Shares		39,158
Stock-based compensation expense	4,958	$ 4,958
Purchase of capped calls related to convertible senior notes	(52,072)	$ (52,072)
Issuance of restricted common stock, Shares		9,772
Foreign currency translation adjustment	(2)		(2)
Net income (loss)	(1,001)			(1,001)
Balance at Jun. 30, 2023	145,213	$ 627,747	(220)	(482,314)
Balance, Shares at Jun. 30, 2023		32,582,933
Balance at Dec. 31, 2023	137,202	$ 641,106	(199)	(503,705)
Balance, Shares at Dec. 31, 2023		32,670,803
Issuance of common stock upon the exercise of common stock options	2,547	$ 2,547
Issuance of common stock upon the exercise of common stock options, Shares		113,023
Issuance of common stock in connection with employee stock purchase plan	638	$ 638
Issuance of common stock in connection with employee stock purchase plan, Shares		9,506
Vesting of restricted stock units, Shares		58,044
Stock-based compensation expense	6,870	$ 6,870
Foreign currency translation adjustment	17		17
Net income (loss)	12,197			12,197
Balance at Mar. 31, 2024	159,471	$ 651,161	(182)	(491,508)
Balance, Shares at Mar. 31, 2024		32,851,376
Balance at Dec. 31, 2023	137,202	$ 641,106	(199)	(503,705)
Balance, Shares at Dec. 31, 2023		32,670,803
Foreign currency translation adjustment	(38)
Net income (loss)	24,391
Balance at Jun. 30, 2024	189,894	$ 669,445	(237)	(479,314)
Balance, Shares at Jun. 30, 2024		33,314,281
Balance at Mar. 31, 2024	159,471	$ 651,161	(182)	(491,508)
Balance, Shares at Mar. 31, 2024		32,851,376
Issuance of common stock upon the exercise of common stock options	10,641	$ 10,641
Issuance of common stock upon the exercise of common stock options, Shares		433,398
Vesting of restricted stock units, Shares		17,772
Issuance of common stock in connection with exercise of warrants, Shares		11,735
Stock-based compensation expense	7,643	$ 7,643
Foreign currency translation adjustment	(55)		(55)
Net income (loss)	12,194			12,194
Balance at Jun. 30, 2024	$ 189,894	$ 669,445	$ (237)	$ (479,314)
Balance, Shares at Jun. 30, 2024		33,314,281